More Cann Group Ltd. news
Cann Group Ltd.ASX: CAN

Granting of New Research and Medicinal Cannabis Licences

Feb 18, 2018 at 10:25 PM EST · Issued by Cann Group Ltd.

Filed with ASX · Feb 18, 2018 at 10:25 PM EST · 2 pages · English

On 6ix: 6ix.com/news/granting-of-new-research-and-medicinal-cannabis-licences

Cann Group Ltd. on 6ix

Earlier from Cann

  • Appendix 4D to Half Yearly Report and AccountsFeb 6, 2018
  • Federal Government Announcement on Medicinal Cannabis ExportJan 3, 2018
  • Cann Group Successfully Completes PlacementDec 3, 2017
  • Fully underwritten $60 million capital raiseNov 30, 2017
  • Cann Group Granted Cannabis Import / Export LicenceOct 26, 2017

Later from Cann

  • Cann executes MOU with Under The Tree BiopharmaceuticalsFeb 22, 2018
  • Receipt of Import Permits for Genetics and Cannabis OilMar 5, 2018
  • S&P DJ Indices Announces March Quarterly RebalanceMar 8, 2018
  • Leading Global Consultancy appointed for Phase 3 facilityApr 19, 2018
  • Quarterly Activities Report and Appendix 4CApr 27, 2018
All Cann news releases↗

Follow Cann into a list and get an email when it puts out news.

Follow Cann
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer